AU1261501A - Compositions and methods for intranasal delivery of active agents to the brain - Google Patents

Compositions and methods for intranasal delivery of active agents to the brain

Info

Publication number
AU1261501A
AU1261501A AU12615/01A AU1261501A AU1261501A AU 1261501 A AU1261501 A AU 1261501A AU 12615/01 A AU12615/01 A AU 12615/01A AU 1261501 A AU1261501 A AU 1261501A AU 1261501 A AU1261501 A AU 1261501A
Authority
AU
Australia
Prior art keywords
brain
compositions
methods
active agents
intranasal delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12615/01A
Inventor
Stanley L. Gore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1261501A publication Critical patent/AU1261501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU12615/01A 1999-12-06 2000-11-03 Compositions and methods for intranasal delivery of active agents to the brain Abandoned AU1261501A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16876299P 1999-12-06 1999-12-06
US60168762 1999-12-06
US70366700A 2000-11-02 2000-11-02
US09703667 2000-11-02
PCT/CA2000/001311 WO2001041732A1 (en) 1999-12-06 2000-11-03 Compositions and methods for intranasal delivery of active agents to the brain

Publications (1)

Publication Number Publication Date
AU1261501A true AU1261501A (en) 2001-06-18

Family

ID=26864429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12615/01A Abandoned AU1261501A (en) 1999-12-06 2000-11-03 Compositions and methods for intranasal delivery of active agents to the brain

Country Status (3)

Country Link
AU (1) AU1261501A (en)
CA (1) CA2325106A1 (en)
WO (1) WO2001041732A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
JP2005503425A (en) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション Delivery of drug ester by the prescribed inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
AU2002363947A1 (en) * 2001-11-21 2003-07-24 Alexza Molecular Delivery Corporation Delivery of caffeine through an inhalation route
CA2526478A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
ES2258694T3 (en) 2003-11-11 2006-09-01 Mattern, Udo ADMINISTRATION SYSTEM FOR CONTROLLED RELEASE OF SEX HORMONES FOR NASAL APPLICATIONS.
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
US20060252738A1 (en) * 2005-05-06 2006-11-09 Phero Tech Inc. Method for preparing and using water-based steroid pheromone compositions
US20090317377A1 (en) 2005-08-26 2009-12-24 Yeomans David C Therapy procedure for drug delivery for trigeminal pain
DK2068825T3 (en) 2006-10-04 2011-05-16 M & P Patent Ag Controlled release delivery system for nasal application of neurotransmitters
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
CN102652815B (en) * 2012-05-09 2013-11-06 武汉市健恒生物科技有限责任公司 Medicament composite for improving memory as well as preparation method and application thereof
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
SI3242676T1 (en) 2015-01-07 2024-02-29 Tonix Pharma Limited Magnesium-containing oxytocin formulations and methods of use
US11813354B1 (en) * 2019-01-11 2023-11-14 Shear Kershman Laboratories, Inc Trans-mucosal delivery system for testosterone
CN114159448A (en) * 2021-12-10 2022-03-11 深圳先进技术研究院 Application of steroid substance in preparation of preparation for improving attention

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
DE3601923A1 (en) * 1986-01-23 1987-07-30 Behringwerke Ag NASAL APPLICABLE MEDICINE, METHOD FOR THE PRODUCTION AND USE THEREOF
IT1222395B (en) * 1987-07-30 1990-09-05 Pierrel Spa PHARMACEUTICAL COMPOSITION FOR INTRANASAL ADMINISTRATION INCLUDING THE HORMONE GHRH, A COLINERGIC AGONIST AND / OR A BILE SALT
ATE156704T1 (en) * 1989-12-05 1997-08-15 Ramsey Foundation NEUROLOGICAL AGENTS FOR NASAL ADMINISTRATION TO THE BRAIN
DE4218291A1 (en) * 1992-06-03 1993-12-09 Mattern Et Partner Pharmazeuti Dosing spray for pernasal application
AU2702795A (en) * 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration
EP0958355A1 (en) * 1996-07-23 1999-11-24 Wilson Trafton Crandall Transdermal transport of molecules
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
BR9711812A (en) * 1996-07-23 1999-08-24 Pherin Pharm Inc Steroids as neurochemical stimulators of the vomeronasal organ to relieve symptoms of pms and anxiety
BR9912508A (en) * 1998-06-29 2001-05-02 Pharmaceuticals Applic Associa Transdermal methods and compositions for pain relief

Also Published As

Publication number Publication date
WO2001041732A1 (en) 2001-06-14
CA2325106A1 (en) 2001-06-06

Similar Documents

Publication Publication Date Title
AU4996300A (en) Method of electroporation-enhanced delivery of active agents
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU1261501A (en) Compositions and methods for intranasal delivery of active agents to the brain
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU2002243277A1 (en) Methods and compositions for encapsulating active agents
AU2001236457A1 (en) Compounds and compositions for delivering active agents
AU5905400A (en) Methods and compositions for delivery and retention of active agents to lymph nodes
AU4460900A (en) Carrier patch for the delivery of agents to the skin
AU2093101A (en) Compositions for efficient release of active ingredients
IL148933A0 (en) Compositions and methods for tumor-targeted delivery of effector molecules
AU2609901A (en) Antimicrobial compositions and methods of use
AU2001284985A1 (en) Compounds and compositions for delivering active agents
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
IL142807A0 (en) Controlled delivery of active agents
AU7620200A (en) Compositions and methods relating to the inhibition of casomorphin and gluteomorphin
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001288277A1 (en) Compounds and compositions for delivering active agents
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU1969800A (en) Combination of active agents
AU6056500A (en) Process and composition for temporarily suppressing pain
AU7792900A (en) Distribution of certifiers
EP1075184A4 (en) Compositions and methods for active vaccination
AU2002316200A1 (en) Compound and composition for delivering active agents
HUP0303178A3 (en) Methods and compositions for reducing the taste of pharmaceutically active agents
AU5802800A (en) Form of administration for applying in body orifices

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase